Caribbean Public Health Agency

Dr. Edwin Cevallos to give a keynote address on the occasion of High Level week during a side event for the United Nations General Assembly on September 18, 2023, Hosted by the Artemis Aspire Foundation

Retrieved on: 
Thursday, September 14, 2023

The United Nations General Assembly serves as a platform for addressing critical global issues, and this keynote on COVID-19 and the strength of the immune system reflects the ongoing importance of pandemic-related concerns.

Key Points: 
  • The United Nations General Assembly serves as a platform for addressing critical global issues, and this keynote on COVID-19 and the strength of the immune system reflects the ongoing importance of pandemic-related concerns.
  • BIRM - DR. EDWIN CEVALLOS
    The Aspire Artemis Foundation is honored to have Dr. Edwin Cevallos as a featured speaker.
  • "We are delighted to have Dr. Edwin Cevallos as a keynote speaker for Aspire Artemis Foundation’s High Level side event on the occasion of the 78th session of the United Nations General Assembly.
  • For media inquiries, interview requests, or additional information about Dr. Edwin Cevallos' participation in the UNGA event hosted by the Artemis Aspire Foundation, please contact:

Co-Diagnostics, Inc. to Host Booth at 67th Annual CARPHA Conference April 27-29

Retrieved on: 
Wednesday, April 26, 2023

The CARPHA Annual Health Research Conference is the largest health research conference in the English-speaking Caribbean and the longest-running health research Conference in Latin America and the Caribbean region, with the goal of facilitating and promoting communication and sharing of scientific outputs among health scientists, policymakers, and related professionals in the wider Caribbean Region.

Key Points: 
  • The CARPHA Annual Health Research Conference is the largest health research conference in the English-speaking Caribbean and the longest-running health research Conference in Latin America and the Caribbean region, with the goal of facilitating and promoting communication and sharing of scientific outputs among health scientists, policymakers, and related professionals in the wider Caribbean Region.
  • The Company's booth will showcase Co-Diagnostics' infectious disease and vector control products to conference attendees, along with its upcoming Co-Dx PCR Home™ testing platform*.
  • Co-Dx has had several important relationships in the Caribbean basin and has regularly attended the annual CARPHA conference since 2016.
  • Attendees interested in learning more about the Company and its products, including its upcoming Co-Dx PCR Home platform, are invited to visit the Company's booth.

St Kitts and Nevis administration vows to continue advancing economy to provide greater social and economic opportunities at first press conference of 2023

Retrieved on: 
Monday, January 23, 2023

“These pledges were based on seven foundational pillars including Food Security, Energy Transition, Economic Diversification, Sustainable Industries, Creative Economy.

Key Points: 
  • “These pledges were based on seven foundational pillars including Food Security, Energy Transition, Economic Diversification, Sustainable Industries, Creative Economy.
  • “We made a pledge to govern with transparency, accountability and integrity and we intend to continue in that vein.
  • The government of St Kitts and Nevis is also looking to recruit new doctors, nurses, technicians, therapists and technologists.
  • The Prime Minister hailed the efficient leadership of the new Head of the Citizenship by Investment Unit of St Kitts and Nevis, Michael Martin.

Co-Diagnostics, Inc. to Sponsor, Present, and Host Booth at 66th Annual CARPHA Conference on Sept 15-17 in Jamaica

Retrieved on: 
Wednesday, September 14, 2022

This year's theme for the conference is "COVID-19 and Digital Health: Transforming, Connecting, Informing Public Health."

Key Points: 
  • This year's theme for the conference is "COVID-19 and Digital Health: Transforming, Connecting, Informing Public Health."
  • Co-Dx has been attending the CARPHA conference since 2016, and the Company's booth and presentation will showcase Co-Diagnostics' infectious disease and vector control products to conference attendees, along with its upcoming Co-Dx PCR Home testing platform.
  • Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technology.
  • The Company's technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA).

Global $37 Billion Bioinformatics Market to 2026: Increasing Bioinformatics Funding from the Public and Private Sectors - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 4, 2021

The bioinformatics market is expected to grow at a compound annual growth rate of 19.36% over the forecast period to reach a market size of US$37.029 billion in 2026 from US$10.728 billion in 2019.

Key Points: 
  • The bioinformatics market is expected to grow at a compound annual growth rate of 19.36% over the forecast period to reach a market size of US$37.029 billion in 2026 from US$10.728 billion in 2019.
  • As a result, growing demand is projected to propel the bioinformatics market throughout the forecast period.
  • The NHS, Public Health Agencies, the Wellcome Sanger Institute, and several academic institutions comprise the COVID-19 Genomics UK Consortium (COG-UK).
  • As a result, manufacturing capacity and bioinformatics supply will be reduced, which is likely to stifle market growth.

AHF Donates SARS-CoV-2 Viral Sequencing Machine to the Caribbean

Retrieved on: 
Tuesday, September 14, 2021

This will improve the regions sequencing capacity and contribute to reducing testing turnaround times.

Key Points: 
  • This will improve the regions sequencing capacity and contribute to reducing testing turnaround times.
  • Dr. Kevin Harvey, the Caribbean Regional Director at AHF, in welcoming the agreement, noted that the machine is already on order and should be in place within the next two to three weeks.
  • AHF is also now in final negotiations to provide support to establishing genomic sequencing capacity in Jamaica to reduce the need for all samples to be sent to Trinidad and Tobago.
  • To learn more about AHF, please visit our website : www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter @aidshealthcare .

Sensiva Health Receives Caribbean Public Health Agency Emergency Use Authorization For Its Sensiva C19™ COVID-19 Test

Retrieved on: 
Tuesday, August 18, 2020

Sensiva Health, LLC, a premier developer and supplier of COVID-19 tests, today announced the Caribbean Public Health Agency (CARPHA) which represents some 24 Caribbean member states has authorized its Sensiva C19 RT-PCR (Polymerase chain reaction) Molecular COVID-19 Test for use throughout the Caribbean region.

Key Points: 
  • Sensiva Health, LLC, a premier developer and supplier of COVID-19 tests, today announced the Caribbean Public Health Agency (CARPHA) which represents some 24 Caribbean member states has authorized its Sensiva C19 RT-PCR (Polymerase chain reaction) Molecular COVID-19 Test for use throughout the Caribbean region.
  • With CARPHAs EUA now officially in place, Sensiva C19 will be widely available for fast, accurate COVID-19 testing throughout the Caribbean, enabling healthcare providers to respond more rapidly to patients health needs during the current health crisis.
  • As members of the global healthcare community, were excited to receive CARPHAs emergency use authorization, said Dave Vigerust, MS, Ph.D., and Sensivas chief scientific & compliance officer.
  • Sensiva Health, LLC offers a variety of direct COVID-19 lab tests for informational and educational use.